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ABSOLUTE CONCENTRATIONS OF DITHRANOL AND 
TRIACETYL-DITHRANOL IN THE SKIN LAYERS AFTER LOCAL TREATMENT: 
IN VIVO INVESTIGATIONS WITH FOUR DIFFERENT TYPES OF 
PHARMACEUTICAL VEHICLES 
B. KAMMERAU, A. ZESCH, M.D., AND H. SCHAEFER, PH.D. 
Dermatology Clinic of the Free University of Berlin, Rudolph-Virchow-Hospital, Berlin, West Germany 
The pharmacokinetics of dithranol (anthralin) and its triacetate were investigated by 
employing a method which determines the quantity of the drug that penetrated into single 
layers of the human skin in vivo. For this purpose, tritium-labeled dithranol or triacetyl-
dithranol was incorporated into four different ointments. The ointments were applied to the 
skin and biopsies were taken after 10, 30, 100, and 1000 min. The horny layer was removed 
before biopsy by Scotch tape stripping. The biopsies were sliced horizontally and the tritium 
determined in each sample. 
Dithranol as well as its triacetate penetrated best from more hydrophobic ointments 
(Vaseline and aqueous wool-wax-alcohol ointment). From hydrophilic ointments (polyethyl-
ene glycol ointment and aqueous hydrophilic cream), only poor penetration was observed. 
Dithranol penetrated in far greater amounts than its triacetate, and the two compounds 
revealed fundamentally different penetration kinetics in epidermis and dermis. The data 
indicate that the triacetate was not split into its parent compound, dithranol. in 
substantial quantity, as the data obtained show the criteria oftwo independent substances. 
The penetration of drugs into the skin after local 
application is an extremely complicated process. 
Experimental approaches to the processes can 
follow two paths: (1) The total skin can be consid-
ered as a physical membrane and the penetration 
of substances through this membrane can be 
observed. This allows generalized conclusions 
about the penetration process, but yields no infor-
mation about absolute concentrations of drugs in 
the skin at a given time. (2) The penetration 
process in various compartments of skin can be 
measured. In this case, valid statements can be 
made only for a definite substance under set condi-
tions. Each alteration in experimental conditions 
(method of application, concentration of substance 
in the ointment. conditions at site of application) 
can lead to alterations in any of the compartments 
and so influence the results. 
The latter approach is of particular importance 
in questions arising in connection with the external 
therapy of dermatoses, if one requires to know the 
concentrations of a selected drug in a definite skin 
layer at a fixed time after application. We under-
took investigations of the penetration kinetics of a 
series of drugs presently applied or under consider-
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ation in external therapy under conditions as near 
as possible to those in clinical situations. We chose 
to study dithranol, an agent whose clinical effects 
are well documented but whose mechanism of 
action remains controversial. A series of hypothe-
ses exist for the mechanism of action of this 
substance based on observations of biochemical, 
molecular biologic, and rnorphokinetic effects of 
the drug in experimental investigations. Exact 
estimations of concentrations in different skin 
layers after therapeutic applications could narrow 
the selection from these hypotheses. Only those 
effects observed at concentrations at or below those 
found in vivo in the skin would be relevant. 
Furthermore, a derivative of dithranol, triacetyl-
dithranol, has been considered as an antipsoriatic 
agent [1]. An hypothesis was developed whereby 
the acetyl groups are split off by the skin est erases 
so that dithranol is liberated. In this way, the 
disadvantages of dithranol (discoloration and in-
flammatory irritation) would be obviated. Ini-
tially, we had to investigate whether and in what 
concentrations triacetyl-dithranol penetrates the 
skin. 
MATERIALS Al\iD METHODS 
Dithranol (anthra-1,8,9-trioll was purchased from 
Bayer, Leverkusen, West Germany, and triacetyl-
dithranol (triacetvl-anthra-1,8,9-triol) from Knoll AG, 
Ludwigshafen, W~st Germany. These substances were 
labeled with tritium (dithranol by a base-catalyzed 
unspecific exchange with tritiated water, and triacetyl-
dithranol by platinum-catalyzed unspecific exchange in 
tritiated acetic acid) by Radiochemicals Amersham, 
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England, with a specific activity of 2.3 mCi/mg each, 
purified by thin-layer radiochromatography and the 
radioactive purity controlled monthly. Batches with 
more than 5% impurity were repurified. Exchange of 
labile tritium against hydrogen in water was checked and 
found to be less than l% per 24 hr at room temperature. 
Labeled substances were mixed with unlabeled drug and 
made up with the 4 ointment bases of the German 
Pharmacoepia (DAB 7) at 0.1% concentration (approxi-
mately 0.2~tCi/mg ointment). The carriers used were: (1) 
a fat-like hydrocarbon mixture (white Vaseline); (2) a 
hydrophobic water-in-oil (w/o) emulsion (aqueous wool-
wax-alcohol ointment); (3) a hydrophobic oil-in-water 
(o/w) emulsion (aqueous hydrophilic ointment); and (4) a 
hydrophilic polyethylene glycol mixture (polyethylene 
glycol ointment). 
Ointment (70-100 mg) was rubbed for 50 sec into a 
28-crn' area of intact human skin. The patients were 
mainly women (37 female, 3 male) 40 years of age or 
more. In order to avoid spreading of ointment, the skin 
was covered with a wire cage until excision. The ointment 
was left on the skin for periods of 10, 30, 100, 300, and 
1000 min. The residue was carefully washed off several 
times by gentle cleaning with cotton and isopropanol and 
the horny layer stripped off using cellotape strips ( 15 ± 5 
times). The horny layer was considered to be 20 11m thick. 
A piece of skin of at least 8 mrn diameter was then 
excised. A 28-mrn' sample of the preparation was sec-
tioned horizontally using a freezing microtome. In control 
specimens the thickness of the epidermis averaged 160 
~tm ( 100-200 ~tm). The underlying layer, the thickness of 
which avera!(ed 1050 ;tm. was regarded as dermis. The 
first 16 sections (10 IJ thick) were therefore termed 
"epidermis, .. and the following 25 sections "dermis." 
The radioactivity of the horny layer on the cellotape 
was measured using a liquid-scintillation counter. Since 
the sticky layer of the cellotape dissolves in the scintilla-
tion fluid, the same mixture (0.8% butyl-PBD; 5% 
Biosolv, Beckman) in toluene could be used for horny 
layer as well as dermis and epidermis. The tissue slices 
were left for 6 hr at 70°C in 0.3 ml of NaOH solution 
(0.5 N) and were neutralized with acetic acid before ad-
dition of scintillation mixture. The measurements (dpm) 
were calculated as percentage and as absolute concentra-
tions for the various layers. The amount of substance in 
the several layers (e.g., horny layer, epidermis, dermis) 
per unit area of tissue is represented as l'g. ern-'; l'g. 
ml- 1 represents the amount of substance in a unit volume 
of l ml; and 11molar indicates the moles of substance in a 
unit volume of 1 liter of the tissue. 
RESULTS 
Figures 1 and 2 display the penetration kinetics 
of dithranol and triacetyl-dithranol in intact 
human skin (in vivo) and allowed the following 
conclusions: 
1. Dithranol and triacetyl-dithranol have two 
completely different types of penetration kinetics. 
2. The penetration of both substances was con-
siderably influenced by the carrier. Lipophilic 
ointment bases, particularly the single-phase base 
Vaseline, allowed the best penetration of both 
drugs into the epidermis. 
3. The maximal amount penetrating into the 
epidermis (160 ll depth) was 0.3 ;<g/cm 2 skin 
surface for dithranol and 0.04 ;<g/cm' for triacetyl-
dithranol in Vaseline. 
4. The maximal dermal concentrations were in 
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reversed relationship: 0.1 !'(g/cm 2 for triacetyl-
dithranol and 0.045 !'(g/cm' for dithranol in Vase-
line. 
Tables I and II show the molar concentrations 
which can be compared with biochemical and 
pharmacologic data. Within 300 min, dithranol 
concentrations of almost 0.1 mmolar may be 
reached in the epidermis when Vaseline is used as 
base, whereas the epidermal concentration of tria-
cetyl-dithranol does not exceed 0.01 mmolar. Dif-
ferent bases influence the distribution of the drugs 
within skin layers and in respect to the application 
time in a different manner. This behavior is 
modified by the drug itself and no general rules can 
be derived. Particularly noteworthy is that the 
usual reservoir function of the horny layer no 
longer pertains with dithranol, particularly with 
lipophilic ointment base. In comparison to many 
other substances, a very high concentration of 
dithranol is found in the epidermis with very low 
levels in the horny layer and dermis (Figs. 3, 4). 
This is not the case with triacetyl-dithranol where 
the horny layer reservoir function applies. 
The quantity of dithranol in the epidermis in 
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FIG. 1. Influence of different bases on penetration 
kinetics of dithranol (~tg·cm _,skin surface) in the human 
epidermis ( x--x) and dermis (e-----•) in vivo. I ~ 
Vaseline; II ~ aqueous wool-wax-alcohol ointment; Ill ~ 
aqueous hydrophilic ointment; lV ~ polyethylene glycol 
ointment. Penetration time: 1()...1000 min. 
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F1c. 2. Influence of different bases on penetration 
kinetics of triacetyl-dithranol (Jlg-cm- 2 skin surface) in 
the human epidermis and dermis. I ~ Vaseline; II ~ 
aqueous wool-wax-alcohol ointment; III ~ aqueous hy-
drophilic ointment; IV ~ polyethylene !(lycol ointment. 
TABLE I. Micromolar concentrations of dithranol after 
30-min and 300-min application timP 
Pene- Aqueous Aqueous Polv-wool-
Skin layer tration Vase- wax- hydro-
ethvlene 
time line alcohol phiHc gl_,·col (min) 
ointment ointment ointment 
Horny layer I 30' 9.91 115.6 22.05 39.67 
300' ;l2.491 120.7 22.51 138.7 
Epidermis I 30' 2.81 0.77 0.79 1.10 
300' 93.66 30.44 2.65 3.58 
Dermis l 30' 0.3~j 0.511 0.041 0.195 I 300' 0.91 1.13 0.034 0.72 
percent of the applied dose decreases with increas-
ing water content or hydrophilic properties of the 
ointment base (Vaseline ~ w/o emulsion ~ o/w 
emulsion ~ polyethylene glycol) (Fig. 3). Tria-
cetvl-dithranol concentrates in the dermis when a 
lir{Jphilic base is used (after 300 min with Vase-
line, after 1000 min with aqueous wool-wax-alcohol 
ointment), tbe dermal values with Vaseline being 
considerably higher than the concentrations found 
in the epidermis. The application of hydrophilic 
ointment bases is pointless for either substance. 
The following advantages are, however, noticeable; 
(1) Triacetyl-dithranol in o/w emulsions pene-
trates just as well into the epidermis as does the 
same medication with Vaseline. (2) Dithranol 
penetrates from both hydrophilic carriers in very 
small but constant amounts {approximately 0.01 
l'g/cm'} into the epidermis. The application of a 
hydrophilic single-phase base (polyethylene glycol) 
brings about a high depot in the horny layer for 
both substances. Further penetration into the 
epidermis and dermis was almost completely 
inpeded in the case of triacetyl-dithranol and 
considerably diminished for dithranol (Figs. 1, 3). 
DISCUSSION 
The antipsoriatic effect of dithranol is proved 
and noncontroversial, although the mechanism of 
action has been only partially defined. Generally 
accepted proof has been forthcoming with respect 
to its cytostatic properties [21 and inhibition of 
RNA-polymerase [31 as well as other enzymes [4]. 
As is usual with in vitro studies, the question has 
been posed as to what extent the results are valid 
for living skin. Thus, it must be ascertained to 
what extent dithranol penetrates to the various 
skin layers under therapeutic conditions. 
Based on fluorescence studies [5], it was hypoth-
esized that dithranol has a cytotoxic effect in the 
first layer of prickle cells after transversing the 
horny layer. Following this, dithranol is immedi-
ately transformed. The inflammation concomitant 
with dithranol therapy can be considered to be the 
result of this cell destruction which is followed in 
the repair stage by the development of or-
thokeratosis. According to this hypothesis, the 
cytostatic effects of dithranol are of no importance 
as the substance itself never reaches the basal cells 
in cytostatic quantities. These contradictory hy-
potheses provoked us to investigate the distribu-
tion of dithranol in the skin after local application 
and to discover which effects are possible in the 
individual skin layers based on the quantity that 
penetrates. A dependence of penetration on the 
carrier is to be expected from previous studies 
[6-12]. Dithranol is usually applied in Vaseline 
because this fat-like hydrocarbon meets both cer-
tain therapeutic requirements in psoriasis as well 
TABLE IL M icromolar concentration of 
triacetyl-dithranol after 30-min and 300-m in application 
time 
Pene- Aqueou."i. Aqueous Polveth-
wool- vfene 
Skin layer tration Vase- wax- hydro- glycol time line alcohol phi lie olnt-(min) 
ointment ointment ment 
Horny I 30' 142.80 176.16 ! 309. I:J 36.49 laver 300' 196.33 265.35 170.16 70.81 
Epidermis, 30' 0.300 1 5.01 
I 2.32 i 0.28 
I 
300' 7.42 2.32 6.43 0.124 
Dermis 30' 0.068 0.190 0.378 0.057 
300' 3.03 0.876 0.61 0.025 
148 KAMMERAL ZESCH, AND SCHAEFER 
~- L 
FIG. 3. Quantity of dithranol determined in the skin 
in vivo in percent of the apphed amount (base• as m F1g. 
l!. 
as the pharmaceutical requirement of stability of 
the substance in the carrier. In the presence of 
water, dithranol undergoes decomposition. 
The present investigations show that dithranol 
penetrates into the epidermis in large quantities 
with Vaseline. The hornv laver does not function as 
either a reservoir or a pe~et;ation barrier [13 ]. This 
unusual behavior requires particular mention. The 
chemical characteristics of the molecule are simi-
lar to known substances with good penetrating 
properties. On the one hand. it possesses a high 
dipole moment due to the unilateral projecting 
oxygen atoms, similarly to dimethylsulfoxide. di-
methvllormamide. acetone. and also water. On the 
othe; hand. hydrogen bonds can form as seen with 
salicylic acid. This property is most distinct in the 
absence of water since the attachment of water. 
present in the outer phase of an emulsion. to the 
dithranol molecule will reduce its dipole moment 
so that the penetration capacity of dithranol 
through the horny layer would be reduced. Poly-
ethylene glycol, a long-chain polar molecule will 
similar!~· lower the penetration of dithranol. After 
application of aqueous hydrophilic ointments and 
particularly the hydrophilic carrier. polyethylene 
glycol. a certain horny layer depot effect is found. 
The penetration rate is simultaneously considera-
blv reduced. This indicates that the liberation of 
th~ drug from the base, stored in the horny layer. is 
diminished. 
If the free hydrophilic groups of dithranol are 
blocked (e.g .. esterified with acetic acid in tria-
cetvl-dithrano!) then, as expected, the physico-
chimical properties of dithranol are altered and as 
a consequence the extremely rapid penetration 
through the human skin is lost. There is no reason 
to assume an active transport in the skin. The fact 
that the concentrations of dithranol in the epider-
mis are higher than in the horny layer therefore 
reflects verv clearlv different physicochemical 
properties of' these two layers. A partition of the 
drug between two phases takes place where one 
phase. the epidermal tissue, has a far greater 
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affinity for the substance than does the horny layer. 
Together with the reduced barrier function of 
the hornv laver this behavior indicates a consider-
ably high absor,ption rate of dithranol. It should be 
emphasized, however, that the largest portion of an 
ointment and its ingredients remains on the sur-
face of the skin as can be seen from Figures 3 and 4. 
The high rate of penetration of dithranol into the 
hornv laver from Vaseline with a correspondingly 
very, high concentration in the epidermis has 
important consequences. Concentrations of be-
tween approximately 1 and 100 JJmolar were ob-
served in the epidermis after a penetration time of 
300 min (Tab. ll. This means that 10-• to 10- • 
moles per liter of epidermal tissue are found. These 
concentrations are cvtotoxic, since the most impor-
tant metabolic pathways of the cells (the respira-
tory chain and glycolysis) are inhibited [2]. 
Since dithranol does not dissolve in water in the 
concentrations to be found in the epidermis, one 
must assume that dithranol is bound to protein. 
Perhaps some dithranol is converted to water-solu-
ble product in the epidermis. This question of 
metabolism should be further investigated by thin-
layer chromatography. The amounts found do not 
preclude that sufficient quantities of unaltered 
dithranol reach the stratum germinativum in cyto-
static levels. It seems not necessary to accept 
mitosis inhibition as the exclusive mechanism of 
action. 
The esterification of dithranol with acetic acid 
and its therapeutic application in psoriasis is 
based. as mentioned. on the advantage of a color-
less transport molecule which is supposed to pene-
trate easily through the horny layer to the epider-
mis. The results presented show that this does not 
occur at a perceptible rate, but rather that the two 
compounds have different penetration kinetics. 
The function of the horny layer as a reservoir and 
barrier is completely upheld in the case of tria-
cetvl-dithranol. The quantities penetrating into the 
epidermis are fairly small: on the other hand. 
considerable quantities gradually concentrate in 
I 
' jl jlllllll I L· I 
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Fro. 4. Quantitv of triacetyl-dithranol determined in 
the skin in vivo in-percent of the applied amount (bases 
as in Fig. li. 
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the dermis. This different behavior of triacetyl-
dithranol relative to dithranol allows us to con-
clude that the former substance is not transformed 
in the skin to dithranol or its metabolites. 
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